Modeling Neurodegeneration in vitro: A Dynamic Study of Tau in a Microfluidic Chamber System via Quantum Dot Labeling
CSEF · 2019 Mammalian Biology Second Award
Overview
Objectives Current research suggests that toxic tau aggregates propagate from neuron to neuron in a prion-like manner. However, no dynamic proof exists to trace tau s transmission and traffic in neurodegeneration. To dynamically image tau s propagation, an in vitro system must be created by 1. constructing biologically functional quantum dot (Qdot) conjugated tau filaments (wild type (WT) and P301L mutation causing tauopathy) and 2. performing the propagation and transport experiments in vitro with a specially designed microfluidic chamber system. Methods I developed a protocol to synthesize tau proteins that could be uptaken by neurons and could conjugate to the Qdot tags for visualization. Results A staining study was conducted for the biotinylated tau s uptake in neurons with Texas Red-Streptavidin. Not only were WT and P301L tau filaments both uptaken, but P301L tau induced aggregation of native tau inside the neuron, suggesting my system accurately reflected tau s clinical behavior. Finally, a live neuronal transport of tau filaments with Qdot-Streptavidin was conducted in the microfluidic chamber which serves as a unique transport environment by isolating neuron axons from soma. This setup allows for clear imaging of tau proteins propagating retrogradely from axon to soma: the first time tau s transport in primary neuron culture has been virtually observed. Conclusions I successfully developed this system to model neurodegeneration and propose that tau filaments (both WT and P301L) were uptaken and traffic from terminal to soma in neurons. My in vitro system may service as a platform for detailed mechanism studies and for drug screening tests to further understand and potentially find cures for tauopathies such as Alzheimer s Disease.
Summary statement
I successfully developed an in vitro system that can serve as a novel dynamic platform for researchers to understand the detailed biological mechanism behind the neurodegeneration process as well as conduct real time drug screening tests to
Help received
I conducted all experimental procedures, data collection, data evaluation, conclusions, and written reports/ presentations by myself. Professor Yanmin Yang and Dr. Wei Wang from the Department of Neurology at Stanford University provided me with project feedback.
Awards (1)
Competition history
- CSEF 2019
Resources
Related projects
ISEF · 2019
Modeling Neurodegeneration in vitro: A Dynamic Study of Tau in a Microfluidic Chamber System via Quantum Dot Labeling
CSEF · 2016
Development of a Novel Microfluidic System to Study Neurodegenerative Disorders
ISEF · 2018
Using CRISPRi to Analyze the Role of Caveolae-Mediated Endocytosis in Tau Uptake of Central Nervous System Culture
ISEF · 2024
Selection and Preclinical Testing of DNA Aptamers as Targeted Tau Therapies: A Novel Approach to Slow the Progression of Tauopathies
AJAS · 2025
Novel VAE Pipeline for Tau Inhibitor Screening in Drosophila Alzheimer's Models
ISEF · 2016
A Neuronal Cell Study Probing Tau Hyperphosphorylation as a Model for Chronic Traumatic Encephalopathy (CTE)
ISEF · 2018
Mechanisms of the Interplay of Tau and Alpha-Synuclein on Tubulin Polymerization Promoting Protein (TPPP/p25)
ISEF · 2021
Tackling Tau: Identifying a Novel Inhibitor for the MSUT-2 Protein based on Quantum Machine Learning for the Identification of Treatments of Neurodegenerative Diseases
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects